Skip to main content


Table 1 Risk factors for post-transplant diabetes development

From: Post-transplant diabetes mellitus

Non-modifiable Potentially modifiable Modifiable
Ethnicity (non-Caucasian) Infections Immunosuppressive Therapy
Age >40 years-old    • HCV    • Tacrolimus
Recipient's gender (M)    • CMV    • Cyclosporine
Donor's gender (M) IGT (pre-transplantation)    • Corticosteroid
Family history of DM      • Sirolimus
HLA   Obesity
HLA (mismatches)   MS components
History of acute rejection   
  1. IGT, Impaired glucose tolerance; MS, Metabolic Syndrome